ArticleCureus2026
Dosimetric Comparison of Deep Inspiration Breath-Hold and Free-Breathing Techniques in Stereotactic Body Radiotherapy for Localized Lung Tumors at a Tertiary Care Center.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Respiratory motion is a major source of geometric uncertainty in lung stereotactic body radiotherapy (SBRT) and may lead to increased irradiation of normal lung tissue and adjacent organs at risk (OARs). Deep inspiration breath-hold (DIBH) is an advanced motion management technique that minimizes tumor motion by immobilizing the target during treatment delivery and increasing lung volume. This study aimed to evaluate the dosimetric advantages of DIBH compared with free breathing (FB) in SBRT for patients with localized lung tumors. Methods Twenty patients with localized lung tumors underwent computed tomography (CT) simulation using both four-dimensional CT (4DCT) FB and DIBH techniques. SBRT plans were generated for each dataset using 6 MV flattening filter-free (FFF) beams with two coplanar partial arcs (180°-220° offset), and dose calculation was performed using the anisotropic analytical algorithm (AAA) in the Eclipse treatment planning system. Identical dose constraints and plan normalization to the planning target volume (PTV) mean dose were applied for both techniques. Image guidance was performed using cone-beam CT (CBCT). Dosimetric parameters for lung volumes, target coverage, and OAR doses were extracted from dose-volume histograms (DVHs). Statistical comparisons were carried out using paired t-tests. Results DIBH significantly increased lung volumes compared with FB, with mean expansion factors of 1.41 and 1.37 for the ipsilateral and contralateral lungs, respectively, and resulted in a 1.45-fold reduction in internal target volume. The mean ipsilateral lung dose was reduced by 36.84% in DIBH plans (7.48 ± 3.57 Gy) compared with FB plans (10.23 ± 4.58 Gy). Statistically significant reductions were also observed in lung V10, V15, and V20 parameters (p < 0.05). DIBH plans demonstrated improved dose conformity (CI: 1.05 ± 0.08) without significant differences in homogeneity or target coverage indices. In addition, doses to critical OARs including the heart, spinal cord, and chest wall were significantly lower in DIBH-SBRT plans. Conclusion DIBH-based SBRT provides significant dosimetric advantages over FB SBRT for localized lung tumors by enhancing target immobilization, increasing lung volume, and reducing radiation exposure to the lungs and surrounding critical organs without compromising target coverage. DIBH is a feasible and effective respiratory motion management strategy in lung SBRT, although appropriate patient selection and training are essential for successful implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.